TITLE

Leptin and the risk of Barrett's oesophagus

AUTHOR(S)
Kendall, B. J.; Macdonald, G. A.; Hayward, N. K.; Prins, J. B.; Brown, I.; Walker, N.; Pandeya, N.; Green, A. C.; Webb, P. M.; Whiteman, D. C.
PUB. DATE
April 2008
SOURCE
Gut;Apr2008, Vol. 57 Issue 4, p448
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Obesity is associated with increased risks of Barrett's oesophagus and oesophageal adenocarcinoma. Alterations in serum leptin and adiponectin, obesity-related cytokines, have been linked with several cancers and have been postulated as potential mediators of obesity-related carcinogenesis; however, the relationship with Barrett's oesophagus remains unexplored. Methods: Serum leptin and adiponectin concentrations were measured on two subsets of participants within a case-control study conducted in Brisbane, Australia. Cases were people aged 18-79 years with histologically confirmed Barrett's oesophagus newly diagnosed between 2003 and 2006. Population controls, frequency matched by age and sex to cases, were randomly selected from the electoral roll. Phenotype and medical history data were collected through structured, self- completed questionnaires. Odds ratios (OR) and 95% Cl were calculated using multivariable logistic regression analysis. Results: In the pilot analysis (51 cases, 67 controls) risks of Barrett's oesophagus were highest among those in the highest quartile of serum leptin (OR 4.6, 95% CI 0.6 to 33.4). No association was seen with adiponectin. In the leptin validation study (306 cases, 309 controls), there was a significant threefold increased risk of Barrett's oesophagus among men in the highest quartile of serum leptin (OR 3.3, 95% Cl 1.7 to 6.6) and this persisted after further adjustment for symptoms of gastro-oesophageal reflux (OR 2.4, 95% Cl 1.1 to 5.2). In contrast, the risk of Barrett's oesophagus among women decreased with increasing serum leptin concentrations. Conclusions: High serum leptin is associated with an increased risk of Barrett's oesophagus among men but not women. This association is not explained simply by higher body mass or gastro-oesophageal reflux among cases. The mechanism remains to be determined.
ACCESSION #
31654666

 

Related Articles

  • Obesity and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: A Mendelian Randomization Study. Thrift, Aaron P.; Shaheen, Nicholas J.; Gammon, Marilie D.; Bernstein, Leslie; Reid, Brian J.; Onstad, Lynn; Risch, Harvey A.; Liu, Geoffrey; Bird, Nigel C.; Wu, Anna H.; Corley, Douglas A.; Romero, Yvonne; Chanock, Stephen J.; Wong-Ho Chow; Casson, Alan G.; Levine, David M.; Rui Zhang; Ek, Weronica E.; MacGregor, Stuart; Weimin Ye // JNCI: Journal of the National Cancer Institute;Nov2014, Vol. 106 Issue 11, p1 

    Background Data from observational studies suggest that body mass index (BMI) is causally related to esophageal adenocarcinoma (EAC) and its precursor, Barrett's esophagus (BE). However, the relationships may be affected by bias and confounding. Methods We used data from the Barrett's and...

  • Barrett's Esophagus: Where Do We Stand? Al Madi, Majid A. // Saudi Journal of Gastroenterology;Jan2009, Vol. 15 Issue 1, p2 

    Barrett's esophagus (BE) is a precursor for esophageal adenocarcinoma, which has an increased incidence rate over the last few decades. Its importance stems from the poor five-year survival of esophageal adenocarcinoma and current data that suggest a survival benefit when surveillance programs...

  • The usefulness of chromoendoscopy with methylene blue in Barrett’s metaplasia and early esophageal carcinoma. Ormeci, N.; Savas, B.; Coban, S.; Palabıyıkoğlu, M.; Ensari, A.; Kuzu, I.; Kursun, N. // Surgical Endoscopy;Mar2008, Vol. 22 Issue 3, p693 

    Barrett’s esophagus is a condition that is premalignant for adenocarcinoma of the esophagus and the esophagogastric junction. Early detection of Barrett’s metaplasia and dysplasia is very important to decrease the mortality and morbidity from esophageal adenocarcinoma cancer. This...

  • Barrett's Esophagus on Repeat Endoscopy: Should We Look More Than Once? Rodriguez, Sarah; Mattek, Nora; Lieberman, David; Fennerty, Brian; Eisen, Glenn // American Journal of Gastroenterology;Aug2008, Vol. 103 Issue 8, p1892 

    BACKGROUND: Barrett's esophagus (BE) is the precursor lesion for esophageal adenocarcinoma. The major risk factor for BE is chronic gastroesophageal reflux disease (GERD). Screening patients with longstanding GERD for BE with upper esophagogastroduodenoscopy (EGD) has become the standard...

  • Editorial: Where Are You and How Do We Find You? The Dilemma of Identifying Barrett's Epithelium Before Adenocarcinoma of the Esophagus. Wong, Roy K. H.; Altekruse, Sean F. // American Journal of Gastroenterology;Jun2009, Vol. 104 Issue 6, p1363 

    The incidence of esophageal adenocarcinoma in white males has been increasing steadily over the past decade. However, attempts to identify the precursor lesion, intestinal metaplasia of the esophagus, or early in-situ cancers have been dismal, with no increase in the diagnosis of early cancers...

  • Receipt of Previous Diagnoses and Endoscopy and Outcome From Esophageal Adenocarcinoma: A Population-Based Study With Temporal Trends. Cooper, Gregory S.; Tzyung Doug Kou; Chak, Amitabh // American Journal of Gastroenterology;Jun2009, Vol. 104 Issue 6, p1356 

    OBJECTIVES:Endoscopic screening of the at-risk population with chronic gastroesophageal reflux disease (GERD) for the presence of intestinal metaplasia or Barrett's esophagus has been suggested as a method to reduce mortality from esophageal adenocarcinoma. There are only limited data regarding...

  • DNA Promoter Hypermethylation of p16 and APC Predicts Neoplastic Progression in Barrett's Esophagus. Wang, Jean S.; Guo, Mingzhou; Montgomery, Elizabeth A.; Thompson, Richard E.; Cosby, Hilary; Hicks, Lisa; Wang, Shelun; Herman, James G.; Canto, Marcia I. // American Journal of Gastroenterology;Sep2009, Vol. 104 Issue 9, p2153 

    OBJECTIVES:Prediction of progression to cancer in patients with Barrett's esophagus (BE) is difficult using current techniques. We determined whether DNA promoter hypermethylation of genes frequently methylated in esophageal adenocarcinoma (p16 and APC) could be used as predictors of progression...

  • Barrett’s Esophagus, Fundoplication, and Cancer. Watson, David I.; Mayne, George C.; Hussey, Damian J. // World Journal of Surgery;Mar2007, Vol. 31 Issue 3, p447 

    The author reflects on the gastro-esophageal reflux and Barrett's esophagus. According to the author, gastro-esophageal reflux and Barrett's esophagus have become increasingly common in all Western countries, underpinning a 300-400% increase in the incidence of esophageal adenocarcinoma. The...

  • Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma. Smith, Eric; De Young, Neville J.; Pavey, Sandra J.; Hayward, Nicholas K.; Nancarrow, Derek J.; Whiteman, David C.; Smithers, B. Mark; Ruszkiewicz, Andrew R.; Clouston, Andrew D.; Gotley, David C.; Devitt, Peter G.; Jamieson, Glyn G.; Drew, Paul A. // Molecular Cancer;2008, Vol. 7, Special section p1 

    Background: Barrett's esophagus (BE) is the metaplastic replacement of squamous with columnar epithelium in the esophagus, as a result of reflux. It is the major risk factor for the development of esophageal adenocarcinoma (EAC). Methylation of CpG dinucleotides of normally unmethylated genes is...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics